About Index Trending news
Analyze
Top 50 Pricing
Histogenics Corporation

Histogenics Corporation

Work at Histogenics Corporation? Add yourself to this profile

Histogenics Corporation

Histogenics is a tissue regeneration company developing breakthrough treatmentsfor long-lasting joint repair.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$30,000,000
Venture capital (Series C)
$49,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$30,000,000 Post-IPO equity
MassDevice

Histogenics raises $30m for NeoCart regenerative knee treatment